Zinc citrate

Identification

Name

Zinc citrate

Accession Number

DB11154

Description

Zinc citrate is a zinc salt of citric acid. It is available as dietary supplements as a treatment of zinc deficiency and source of zinc, which is an essential trace element. Zinc citrate demonstrates effective absorption following oral administration ¹.

Type

Small Molecule

Groups

Investigational

Structure

Download

MOLSDFPDBSMILESInChI

Similar Structures

Structure for Zinc citrate (DB11154)

×

Close

Weight

Average: 574.34
Monoisotopic: 569.794481

Chemical Formula

C₁₂H₁₀O₁₄Zn₃

Synonyms

• Citric acid, zinc salt
• Trizinc dicitrate

Pharmacology

Indication

Not Available

Contraindications & Blackbox Warnings

Learn about our commercial Contraindications & Blackbox Warnings data.

Learn More

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Learn about our commercial Adverse Effects data.

Learn More

Toxicity

Not Available

Affected organisms

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drug	Interaction
Unlock Additional Data
Abciximab	The risk or severity of bleeding can be increased when Abciximab is combined with Zinc citrate.
Aceclofenac	The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Zinc citrate.
Acemetacin	The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Zinc citrate.
Acenocoumarol	The risk or severity of bleeding can be increased when Acenocoumarol is combined with Zinc citrate.
Acetylsalicylic acid	Acetylsalicylic acid may increase the anticoagulant activities of Zinc citrate.
Albutrepenonacog alfa	The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Zinc citrate.
Alclofenac	The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Zinc citrate.
Aldesleukin	The risk or severity of bleeding can be increased when Zinc citrate is combined with Aldesleukin.
Alemtuzumab	The risk or severity of bleeding can be increased when Zinc citrate is combined with Alemtuzumab.
Alteplase	The risk or severity of bleeding can be increased when Alteplase is combined with Zinc citrate.

Additional Data Available

Extended Description
Extended Description
Available for Purchase
Extended description of the mechanism of action and particular properties of each drug interaction.
Learn more
Severity
Severity
Available for Purchase
A severity rating for each drug interaction, from minor to major.
Learn more
Evidence Level
Evidence Level
Available for Purchase
A rating for the strength of the evidence supporting each drug interaction.
Learn more
Action
Action
Available for Purchase
An effect category for each drug interaction. Know how this interaction affects the subject drug.
Learn more

Food Interactions

• Avoid milk and dairy products. Separate the use of zinc from these products by at least 2 hours before administration. Separate for 2 hours after administration if these products also contain phosphorus.
• Do not take with bran and high fiber foods. For optimal absorption, take zinc citrate at least 2 hours before or after eating high-fiber foods.
• Take on an empty stomach. Take at least 1 hour before and 2 hours after eating for optimal absorption. Zinc can be taken with food to reduce gastrointestinal upset.

Products

Product Ingredients

Ingredient	UNII	CAS	InChI Key
Zinc citrate trihydrate	GNM26GAX7R	178326-57-3	VSJRDSLPNMGNFG-UHFFFAOYSA-H

Active Moieties

Name	Kind	UNII	CAS	InChI Key
Zinc	unknown	J41CSQ7QDS	7440-66-6	HCHKCACWOHOZIP-UHFFFAOYSA-N
Citric acid	unknown	XF417D3PSL	77-92-9	KRKNYBCHXYNGOX-UHFFFAOYSA-N
Zinc cation	ionic	13S1S8SF37	23713-49-7	PTFCDOFLOPIGGS-UHFFFAOYSA-N

Product Images

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Colgate Total Zx Pro-Shield Plus Sensitive	Zinc citrate trihydrate (20 mg/1g) + Potassium nitrate (50 mg/1g) + Sodium fluorophosphate (2 mg/1g)	Paste, dentifrice	Dental	Colgate-Palmolive	2013-02-01	2013-09-01
Palm Springs Multvit and Min Tab	Zinc citrate (1.25 mg) + Ascorbic acid (10 mg) + Biotin (50 mcg) + Calcium carbonate (133.4 mg) + Cholecalciferol (33.4 unit) + Chromic chloride (8.4 mcg) + Cyanocobalamin (1 mcg) + DL-alpha tocopheryl acetate (5 unit) + Ferrous fumarate (1.5 mg) + Folic acid (.0667 mg) + Nicotinamide (3.4 mg) + Calcium pantothenate (1.7 mg) + Potassium Iodide (8.3 mcg) + Pyridoxine hydrochloride (.34 mg) + Riboflavin (.29 mg) + Thiamine mononitrate (.25 mg) + Vitamin A acetate (417 unit)	Tablet	Oral	L & S Research Corporation	1993-12-31	1996-09-09
Prenatal Chelated Mineral	Zinc citrate (5 mg/1) + Calcium carbonate (30 mg/1) + Calcium citrate tetrahydrate (32.5 mg/1) + Copper gluconate (0.5 mg/1) + Ferrous fumarate (7 mg/1) + Magnesium citrate (75 mg/1) + Potassium Iodide (75 ug/1)	Tablet	Oral	Usana Health Sciences, Inc.	2012-04-11	2017-12-31

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Dialyvite 3000	Zinc citrate (15 mg/1) + Ascorbic acid (100 mg/1) + Biotin (300 ug/1) + Cobalamin (1 mg/1) + Folic acid (3 mg/1) + Nicotinamide (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (1.7 mg/1) + Selenocysteine (70 ug/1) + Thiamine mononitrate (1.5 mg/1) + alpha-Tocopherol succinate (30 [iU]/1)	Tablet, coated	Oral	Hillestad Pharmaceuticals Usa	2004-02-01	Not applicable
Dialyvite 5000	Zinc citrate (25 mg/1) + Ascorbic acid (100 mg/1) + Biotin (300 ug/1) + Cobalamin (2 mg/1) + Folic acid (5 mg/1) + Nicotinamide (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (50 mg/1) + Riboflavin (1.7 mg/1) + Selenocysteine (70 ug/1) + Thiamine mononitrate (1.5 mg/1) + alpha-Tocopherol succinate (30 [iU]/1)	Tablet, coated	Oral	Hillestad Pharmaceuticals Usa	2008-05-01	Not applicable
Dialyvite Supreme D	Zinc citrate (15 mg/1) + Ascorbic acid (100 mg/1) + Biotin (300 ug/1) + Cholecalciferol (2000 [iU]/1) + Cobalamin (1 mg/1) + Folic acid (3 mg/1) + Nicotinamide (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (1.7 mg/1) + Selenocysteine (70 ug/1) + Thiamine mononitrate (1.5 mg/1) + alpha-Tocopherol succinate (30 [iU]/1)	Tablet, coated	Oral	Hillestad Pharmaceuticals Usa	2010-09-08	Not applicable
Dialyvite with Zinc	Zinc citrate (50 mg/1) + Ascorbic acid (100 mg/1) + Biotin (300 ug/1) + Cobalamin (6 ug/1) + Folic acid (1 mg/1) + Nicotinamide (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (10 mg/1) + Riboflavin (1.7 mg/1) + Thiamine mononitrate (1.5 mg/1)	Tablet, coated	Oral	Hillestad Pharmaceuticals Usa	2002-10-01	Not applicable
Prenatal Chelated Mineral	Zinc citrate (5 mg/1) + Calcium carbonate (30 mg/1) + Calcium citrate tetrahydrate (32.5 mg/1) + Copper gluconate (0.5 mg/1) + Ferrous fumarate (7 mg/1) + Magnesium citrate (75 mg/1) + Potassium Iodide (75 ug/1)	Tablet	Oral	Usana Health Sciences, Inc.	2012-04-11	2017-12-31

Categories

Drug Categories

• Anticoagulants
• Calculi Dissolution Agent
• Copper Absorption Inhibitor
• Metal cations
• Metal divalent cations
• Zinc Compounds

Chemical TaxonomyProvided by Classyfire

Description

This compound belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups.

Kingdom

Organic compounds

Super Class

Organic acids and derivatives

Class

Carboxylic acids and derivatives

Sub Class

Tricarboxylic acids and derivatives

Direct Parent

Tricarboxylic acids and derivatives

Alternative Parents

Tertiary alcohols / Carboxylic acid salts / Organic transition metal salts / Carboxylic acids / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds

Substituents

Alcohol / Aliphatic acyclic compound / Carbonyl group / Carboxylic acid / Carboxylic acid salt / Hydrocarbon derivative / Organic oxide / Organic oxygen compound / Organic salt / Organic transition metal salt

Molecular Framework

Not Available

External Descriptors

Not Available

Chemical Identifiers

UNII

K72I3DEX9B

CAS number

546-46-3

InChI Key

WGIWBXUNRXCYRA-UHFFFAOYSA-H

InChI

InChI=1S/2C6H8O7.3Zn/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6

IUPAC Name

trizinc(2+) ion bis(2-hydroxypropane-1,2,3-tricarboxylate)

SMILES

[Zn++].[Zn++].[Zn++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

References

General References

1. Wegmuller R, Tay F, Zeder C, Brnic M, Hurrell RF: Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide. J Nutr. 2014 Feb;144(2):132-6. doi: 10.3945/jn.113.181487. Epub 2013 Nov 20. [PubMed:24259556]

External Links

PubChem Compound

11023

PubChem Substance

347827923

ChemSpider

10557

RxNav

236911

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Tablet, film coated	Oral	15 mg
Tablet, effervescent	Oral	15 mg
Liquid	Oral	38 mg
Capsule	Oral
Paste, dentifrice	Dental
Tablet, coated	Oral
Tablet	Oral
Tablet	Oral	10 mg

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
Water Solubility	6.11 mg/mL	ALOGPS
logP	0.04	ALOGPS
logP	-1.3	ChemAxon
logS	-2	ALOGPS
pKa (Strongest Acidic)	3.05	ChemAxon
pKa (Strongest Basic)	-4.2	ChemAxon
Physiological Charge	-3	ChemAxon
Hydrogen Acceptor Count	7	ChemAxon
Hydrogen Donor Count	1	ChemAxon
Polar Surface Area	140.62 Å2	ChemAxon
Rotatable Bond Count	10	ChemAxon
Refractivity	68.14 m3·mol-1	ChemAxon
Polarizability	14.23 Å3	ChemAxon
Number of Rings	0	ChemAxon
Bioavailability	1	ChemAxon
Rule of Five	No	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	No	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Not Available

×

Unlock Data

There is additional data available for commercial users including Adverse Effects, Contraindications, and Blackbox Warnings. Contact us to learn more about these and other features.

Learn more

Drug created on December 03, 2015 09:51 / Updated on June 12, 2020 10:53